During its inquiry, the Commission collected over 70 written contributions, held four days of oral evidence sessions and met with numerous stakeholders, including national health, education and regulatory bodies, individual researchers, innovators, start-ups, digital technology firms, educators, patient charities, clinical commissioners and managers.